dr. rachel v. gow
I’ve gained a great deal of experience and skill in the design, administration,
management and life-cycle of clinical trials, from the initial design ideas to
the subsequent stages of protocol writing, ethical approval, recruitment,
management of trial activity, timelines and expenditure, and through to the
final stages of completion, statistical analyses and write up. My first
experience in this area was in 2007, when I assisted in a phase III clinical
trial testing the safety and efficacy of omega-3 fatty acids in children and
adolescents with ADHD. The principle investigator of this trial was Professor
Eric Taylor (Emeritus), who at the time was head of the Department of Child and
Adolescent Psychiatry at the Institute of Psychiatry, Kings College, London. The
clinical trial was named the Maudsley Adolescent ADHD Fatty Acid trial (MAAFA).
It was the pioneering idea of Professor Taylor and a novel effort to combine the
fields of psychiatry and nutrition.
